1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Falling Comet
Download real time

868.85 24.45 (2.90%)

34.39% Fall from 52W High

1.2M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
19S
7W
3O
2T
87,426.6

Market Cap

High in industry
18.7

PE TTM

Below industry Median
0.3

PEG TTM

PEG TTM is less than 1
4

Price to Book

Above industry Median
0.9

Beta 1Year

Low volatility
US FDA Approval
Zydus Life receives final approval from the US FDA to manufacture Jaythari (Deflazacort) tablets See details

Zydus Lifesciences Ltd. - ZYDUSLIFE - stock price prediction, stock forecast, target price, analyst ratings from 31 analysts

Zydus Lifesciences Ltd. has a share price target of Rs 1059, revenue growth forecast of 17.5%, and profit growth estimate of 20.4% for FY25, based on top 31 analyst calls.

Forecaster Screeners